|Bid||86.01 x 800|
|Ask||86.07 x 4000|
|Day's Range||86.01 - 86.74|
|52 Week Range||76.41 - 89.72|
|PE Ratio (TTM)||38.04|
|Forward Dividend & Yield||1.84 (2.12%)|
|1y Target Est||N/A|
Let's check out the Yahoo Finance charts of the day. United Rentals (URI): Shares are up in early trade, at around 3.6%. UBS upgraded the equipment rental company to "buy" from "neutral". UBS said cyclical and cost concerns surrounding the company are overdone. Blackberry (BB): Shares down here, at 6.9%. The software and services company saw revenue top estimates. Blackberry reported adjusted first-quarter profit of 3 cents per share, compared to analysts' expectations of a breakeven quarter. Medtronic (MDT): Shares are up slightly here, at around .82%. The medical device company said Friday its board has approved a 9% increase in its quarterly cash dividend to 50 cents a share. For more on today's big stock movers check out the Final Round, live at 3:55 p.m. ET, right here on Yahoo Finance.
Jim Cramer sits down with Medtronic Chairman and CEO Omar Ishrak, who shares insights about his company's fastest growing products.
Harley plans to shift production of motorcycles intended for EU purchase out of the U.S. to its international facilities, but that this may take up to 18 months to complete. Netflix NFLX - Chief communications officer Jonathan Friedland is resigning. The company did not give details on why Friedland was leaving, but he tweeted that he had spoken in an “insensitive” manner.
The medical device maker announced Thursday the FDA approved its t:slim X2 Insulin pump with Basal-IQ technology. Tandem Diabetes expects to make the t:slim X2 pump with Basal-IQ technology available in the U.S. in August.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 21) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) FibroGen Inc (NASDAQ: ...
BlackBerry BB-CA – BlackBerry reported adjusted first-quarter profit of 3 cents per share, compared to analysts' expectations of a breakeven quarter. JPMorgan Chase JPM , Bank of America BAC , Citigroup C , Wells Fargo WFC – These and other bank stocks are on watch today after 35 of the nation's largest banks passed the Fed's latest stress tests. The software provider's revenue also beat forecasts on strong demand from large companies, but its current-quarter and full-year revenue forecasts are short of analysts' estimates due to a strengthening dollar.
MARKET PULSE Medtronic Plc (mdt) said Friday its board has approved a 9% increase in its quarterly cash dividend to 50 cents a share. The new dividend payment will be made on July 25 to shareholders of record as of July 6.
May marked the 92nd straight month in which U.S. employers added workers to their collective ranks. However, Minnesota's biggest public companies aren't all adding employees.
Medtronic's (MDT) receipt of FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral Drug-Coated Balloon (DCB) is expected to boost the top line.
Zacks Industry Outlook Highlights: Boston Scientific, Stryker, Medtronic, Abbott and Varian Medical
Biotech stocks are also capitalizing on AI’s potential to deliver revolutionary drugs and speed up drug discovery. “I believe that AI is a sleeping giant for healthcare in general,” Eric Horvitz, director of Microsoft Research Labs, said earlier this year.
Medtronic's (MDT) ActivaProgramming Application is designed for use with Samsung Galaxy Tab S2 tablets. The therapy incorporates the inputs of more than a 100 clinicians worldwide.
One of the stocks we analyzed in Tuesday's Daily Market Commentary webinar was Tandem Diabetes Care Inc. ( TNDM), a medical instruments stock that after dropping from a high of $302.50 in early 2014 to a low of $2.14 in early 2018 has suddenly rebounded more than 700% during the past four months. TNDM is flying high on the hope the company is going to successfully bring its closed-loop, artificial pancreas system to market before its rivals Medtronic PLC ( MDT) and Insulet Corp. ( PODD) introduce theirs. Should it be successful, TNDM could lock up market dominance in the diabetes market for years to come.
Intuitive Surgical is about to face a lot more competition as Medtronic, Google, J&J and others roll out robotic surgery systems. But analysts see plenty of room for industry growth. Patients and investors should benefit.
Even if Boston Scientific's (BSX) position remains indefinite on a possible sell-off rumor, the company's strategic stance on this might however, swing in its favor for winning a competitive marketing edge.
According to recent reports, Stryker recently approached Boston Scientific Corporation with its takeover offer. Both Boston Scientific Corporation and Stryker create medical devices. If Stryker and Boston Scientific Corporation were to become a single company, they would have a new market cap of $110 billion.
For investors with a long-term horizon, examining earnings trend over time and against industry peers is more insightful than looking at an earnings announcement in one point in time. InvestorsRead More...
If so, here are some of Jim Cramer's top takeaways. Ishrak said that Medtronic was founded in 1950 with the original pacemaker, a Walkman-sized device that was worn on your belt. Medtronic is using similar technology to stimulate the spine and manage chronic pain.